Catalyst

Slingshot members are tracking this event:

Chronos has acquired three pre-clinical programmes from a subsidiary of Shire PLC

Source Link:
http://1kngsgf1f3e13e11o1i6ikav.wpengine.netdna-cdn.com/wp-content/uploads/2016/07/Chronos-Shire-Press-Release-Final-July-2016.pdf

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SHPG
100%
Chronos
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Chronos announced the acquisition of three pre-clinical development programmes targeting Central Nervous System (CNS) diseases from a subsidiary of Shire Plc.
http://1kngsgf1f3e13...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jul 20, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Pre-clinical Programmes, Chronoscreen, Als, Lou Gehrig's Disease, Central Nervous System Disease
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.